Denali Therapeutics Inc. (DNLI)

Denali Therapeutics Statistics

Total Valuation

DNLI has a market cap or net worth of $3.31 billion. The enterprise value is $2.37 billion.

Market Cap	3.31B
Enterprise Value	2.37B

Important Dates

The last earnings date was Thursday, February 26, 2026, after market close.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

DNLI has 156.16 million shares outstanding. The number of shares has increased by 4.97% in one year.

Current Share Class	156.16M
Shares Outstanding	156.16M
Shares Change (YoY)	+4.97%
Shares Change (QoQ)	+1.76%
Owned by Insiders (%)	4.53%
Owned by Institutions (%)	97.65%
Float	141.93M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	140.80
PB Ratio	3.26
P/TBV Ratio	3.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.16, with a Debt / Equity ratio of 0.03.

Current Ratio	9.16
Quick Ratio	8.82
Debt / Equity	0.03
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -45.69% and return on invested capital (ROIC) is -368.88%.

Return on Equity (ROE)	-45.69%
Return on Assets (ROA)	-27.56%
Return on Invested Capital (ROIC)	-368.88%
Return on Capital Employed (ROCE)	-53.07%
Weighted Average Cost of Capital (WACC)	9.75%
Revenue Per Employee	n/a
Profits Per Employee	-$991,373
Employee Count	517
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, DNLI has paid $102,000 in taxes.

Income Tax	102,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +12.12% in the last 52 weeks. The beta is 1.02, so DNLI's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	+12.12%
50-Day Moving Average	19.03
200-Day Moving Average	16.16
Relative Strength Index (RSI)	56.29
Average Volume (20 Days)	1,704,103

Short Selling Information

The latest short interest is 13.59 million, so 8.71% of the outstanding shares have been sold short.

Short Interest	13.59M
Short Previous Month	13.56M
Short % of Shares Out	8.71%
Short % of Float	9.58%
Short Ratio (days to cover)	7.99

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-555.34M
Pretax Income	-512.44M
Net Income	-512.54M
EBITDA	-540.53M
EBIT	-555.34M
Earnings Per Share (EPS)	-$2.97

Balance Sheet

The company has $867.88 million in cash and $32.74 million in debt, with a net cash position of $933.46 million or $5.98 per share.

Cash & Cash Equivalents	867.88M
Total Debt	32.74M
Net Cash	933.46M
Net Cash Per Share	$5.98
Equity (Book Value)	1.01B
Book Value Per Share	6.49
Working Capital	802.31M

Cash Flow

In the last 12 months, operating cash flow was -$412.60 million and capital expenditures -$9.50 million, giving a free cash flow of -$422.10 million.

Operating Cash Flow	-412.60M
Capital Expenditures	-9.50M
Free Cash Flow	-422.10M
FCF Per Share	-$2.70

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

DNLI does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-4.97%
Shareholder Yield	-4.97%
Earnings Yield	-15.50%
FCF Yield	-12.76%

Analyst Forecast

The average price target for DNLI is $30.80, which is 45.42% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.80
Price Target Difference	45.42%
Analyst Consensus	Strong Buy
Analyst Count	12
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1